Health – Town Fort Lauderdale

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up
on July 14, 2026 at 3:34 pm
Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
on July 11, 2026 at 12:00 pm
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
on July 11, 2026 at 5:00 am
For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
on July 10, 2026 at 10:10 am
Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
on July 9, 2026 at 6:44 pm
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it
on July 8, 2026 at 6:25 pm
About 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same percentage as 2025 and up from 34% in 2024, the survey said.
Jim Cramer says these are the 5 stocks to buy during this market rotation
on July 6, 2026 at 10:29 pm
CNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies.